The goal of the Biostatistics and Data Management Core Facility is to provide statistical analytic collaboration and data management support members of the UNC Lineberger Comprehensive Cancer Center. Biostatistical services include research/protocol design and data analysis for clinical trials, and for epidemiologic, cancer prevention and control, and basic science studies. Data management services involve the development, integration, and management of cancer research data, particularly patient-related data. The Core is led by Drs. Michael Schell and Joseph Ibrahim. The Core adds value to the Center by providing critical analytic and data management support to the key research activities of the Cancer Center. Highlights of research supported by the Core include LCCC 9719, a 230-patient multi-center clinical trial of advanced stage lung cancer (PI: Dr. Mark Socinski), and the identification of a target recall rate for mammographers (PI: Dr. Bonnie Yankaskas). Over the past five years, the use of the Facility has grown. During the past year, a data management group has been added to the Facility, and a major database effort has been launched. Future plans for the Core include recruitment of a second full-time faculty biostatistician, further integration of Biostatistics and Statistics faculty on specific research problems requiring specialized expertise, and continued development of an integrated database system.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-33
Application #
7645552
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
33
Fiscal Year
2008
Total Cost
$774,542
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hall, Marissa G; Marteau, Theresa M; Sunstein, Cass R et al. (2018) Public support for pictorial warnings on cigarette packs: an experimental study of US smokers. J Behav Med 41:398-405
Ma, Shaohua; Paiboonrungruan, Chorlada; Yan, Tiansheng et al. (2018) Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target. Ann N Y Acad Sci 1434:164-172
Aung, Kyaw L; Fischer, Sandra E; Denroche, Robert E et al. (2018) Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial. Clin Cancer Res 24:1344-1354
Suh, Junghyun L; Watts, Brian; Stuckey, Jacob I et al. (2018) Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry 57:2140-2149
Brock, William J; Beaudoin, James J; Slizgi, Jason R et al. (2018) Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease. Int J Toxicol 37:144-154
Thomas, Nancy E; Edmiston, Sharon N; Tsai, Yihsuan S et al. (2018) Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. Am J Dermatopathol :
Bensen, Jeannette T; Graff, Mariaelisa; Young, Kristin L et al. (2018) A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Res 20:45
Parr, Jonathan B; Lodge, Evans K; Holzmayer, Vera et al. (2018) An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots. Clin Infect Dis 66:254-260
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Wu, Bing; Zhang, Song; Guo, Zengli et al. (2018) RAS P21 Protein Activator 3 (RASA3) Specifically Promotes Pathogenic T Helper 17 Cell Generation by Repressing T-Helper-2-Cell-Biased Programs. Immunity 49:886-898.e5

Showing the most recent 10 out of 1525 publications